Fagan Associates’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,595
Closed -$315K 111
2023
Q2
$315K Buy
2,595
+170
+7% +$20.7K 0.08% 94
2023
Q1
$372K Buy
+2,425
New +$372K 0.09% 95